| Financial Year |
March 31 2023 |
| Monetary Funds |
886,586,282.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,007,277.83 |
| Accounts Receivable |
2,101,498,527.04 |
| Advances to Suppliers |
148,150,383.67 |
| Other Receivables |
65,708,260.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,239,320,402.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,964,762.03 |
| Total Current Assets |
4,522,994,929.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,594,818.38 |
| Investment Properties |
-- |
| Fixed Assetes |
490,235,660.68 |
| Under-construction Projects |
17,152,483.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,174,712.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
49,171,844.94 |
| Deferred Income Tax Assets |
44,610,282.72 |
| Other Non-Current Assets |
371,489,757.40 |
| Sub-Total of Non-Current Assets |
1,230,695,016.14 |
| Total Assets |
5,753,689,945.80 |
| Short-Term Loans |
811,635,343.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,941,550.80 |
| Accounts Payable |
450,452,201.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
80,696,332.42 |
| Taxes Payable |
6,885,869.31 |
| Interest Payable |
1,431,666.85 |
| Dividend Payable |
-- |
| Other payables |
29,660,826.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,637,394.01 |
| Other Current Liabilities |
66,434,094.88 |
| Sub-Total of Current Liabilities |
1,830,254,425.74 |
| Long-term Loans |
176,614,925.25 |
| Bonds Payable |
916,055,490.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
217,500.00 |
| Deferred Income Tax Liabilities |
8,635,821.55 |
| Other Non-Current Liabilities |
3,864,534.93 |
| Sub-Total of Non-Current Liabilities |
1,293,618,116.51 |
| Total Liabilities |
3,123,872,542.25 |
| Paid-In Capital(Or Share Stock) |
185,636,281.00 |
| Capital Surplus |
1,651,316,165.33 |
| Surplus Reserve |
84,901,085.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
603,996,525.52 |
| Minority Stockholder's Interest |
13,662,156.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,616,155,247.49 |
| Owner's Equity（Stockholder's Equity） |
2,629,817,403.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,753,689,945.80 |
